Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.3 USD | +0.43% | +1.64% | +24.83% |
May. 08 | Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Financials (USD)
Sales 2022 | 4.81M | Sales 2023 | 2.13M | Capitalization | 13.57M |
---|---|---|---|---|---|
Net income 2022 | -113M | Net income 2023 | -62M | EV / Sales 2022 | -17.6 x |
Net cash position 2022 | 96.61M | Net cash position 2023 | 57.06M | EV / Sales 2023 | -20.4 x |
P/E ratio 2022 |
-0.11
x | P/E ratio 2023 |
-0.22
x | Employees | 99 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.68% |
Latest transcript on Talis Biomedical Corporation
1 day | +0.43% | ||
1 week | +1.64% | ||
Current month | +7.89% | ||
1 month | +9.36% | ||
3 months | +21.25% | ||
6 months | +61.74% | ||
Current year | +24.83% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Kelley
CEO | Chief Executive Officer | 52 | 20-08-31 |
Director of Finance/CFO | 51 | 21-12-31 | |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 56 | 16-02-29 |
Randal Scott
BRD | Director/Board Member | 66 | 13-12-31 |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 9.3 | +0.43% | 5,556 |
24-05-09 | 9.26 | +0.54% | 11,873 |
24-05-08 | 9.21 | -0.97% | 4,118 |
24-05-07 | 9.3 | +1.53% | 14,220 |
24-05-06 | 9.16 | +0.11% | 10,762 |
Delayed Quote Nasdaq, May 10, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+24.83% | 16.94M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- TLIS Stock